Basic Information
Basic information for FTX-228-14aa
Peptide Name FTX-228-14aa
Genome Position chrX:74203691-74203732[-]
Species Human
Peptide Sequence MPATLSPARGLGTT
Peptide Length 14
Unique No (FTX-202-14aa,FTX-210-14aa-1,FTX-218-14aa-2,FTX-223-14aa,FTX-224-14aa,FTX-229-14aa,FTX-231-14aa,FTX-233-14aa,FTX-236-14aa,FTX-238-14aa,FTX-241-14aa,FTX-245-14aa,FTX-257-14aa,FTX-261-14aa,FTX-264-14aa,FTX-265-14aa,FTX-266-14aa,FTX-268-14aa)
Grand Average of Hydropathicity 0.1214
Relative Molecular Mass 1606.9
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000652331;FTX-228
Transcript Length 1996
Coding Ability 0.5271
DNA Sequence Corresponding to Peptide ATGCCTGCAACACTGTCACCTGCACGTGGATTGGGAACCACA
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :